Skip to content
Screener

LeMaitre Vascular LMAT Net Change in Cash

Net Change in Cash at other companies

ITG
Integer HoldingsITGR
-$9.05M+39.0%
Abbott logo
AbbottABT
-$1.7B
Baxter International logo
Baxter InternationalBAX
$51M+143%
Becton, Dickinson and Company logo
Becton, Dickinson and CompanyBDX
-$152M
Artivion logo
ArtivionAORT
$21.55M+36.6%
Edwards Lifesciences logo
Edwards LifesciencesEW
-$492M-647%

Other financials

Income statement

See full
Revenue$70.4M+9.6%
Gross profit$50.8M+12.9%
Operating income$20.4M+26.4%
Net income$17.1M+23.7%
EPS (diluted)$0.74+23.3%

Balance sheet

See full
Cash & equivalents$26.6M-2.0%
Total debt$21.2M+19.7%
Total equity$420.3M+15.9%
Total assets$640.5M+10.9%

Cash flow

See full
Operating cash flow$16.0M-21.3%
CapEx$2.3M+72.4%
Free cash flow$13.7M-28.0%

Valuation

See full
Market cap$1.85B-12.4%
Enterprise value$1.84B-12.3%
P/E28.1×-16.6×
P/S-2.0×

Profitability

See full
Gross margin72.9%+3.8pp
Operating margin29.5%+6.1pp
Net margin25%+4.9pp
FCF margin28.1%+5.8pp

Returns & leverage

See full
Return on equity16.8%+3.0pp
Debt / equity0.1×0.0×
Current ratio16.3×+2.4×

Where this comes from

Reported directly by LeMaitre Vascular in its filing.

Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect.

The source filing: LeMaitre Vascular’s 10-Q, filed August 5, 2026.

Filed
Aug 5, 2026, 6:30 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001193125-26-333762
Line itemFor the six months ended / June 30, 2026For the six months ended / June 30, 2025
Common stock cash dividend paid(11,427)(9,037)
Net cash used in financing activities(8,271)(8,003)
Effect of exchange rate changes on cash and cash equivalents(207)909
Net (decrease) increase in cash and cash equivalents(1,619)1,567
Cash and cash equivalents at beginning of period28,24425,610
Cash and cash equivalents at end of period$26,625$27,177
Non-cash operating activities
Right-of-use assets obtained in exchange for new operating lease obligations$6,233$788

Item 1. Financial Statements

FAQ

What is LeMaitre Vascular's net change in cash?
LeMaitre Vascular (LMAT) reported net change in cash of -$226K in Q2 2026.
How has LeMaitre Vascular's net change in cash changed year-over-year?
LeMaitre Vascular's net change in cash decreased by 112.3% year-over-year, from $1.84M to -$226K.
What is the long-term trend for LeMaitre Vascular's net change in cash?
Over 2 years (2023 to 2025), LeMaitre Vascular's net change in cash has grown at a -28.4% compound annual growth rate (CAGR), from $5.14M to $2.63M.
What does net change in cash mean?
Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.

Ask your AI about LeMaitre Vascular's net change in cash.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude